Correction: Time to adjuvant chemotherapy after cytoreductive surgery and survival outcomes in epithelial ovarian cancer: a retrospective cohort study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Impact of Timing for Adjuvant Chemotherapy Following Cytoreductive Surgery on Survival in Epithelial Ovarian Cancer: A Retrospective Cohort Analysis

  • By

  • Kshitij Jamdade

  • Marios Katsanevakis

  • Tobechi Njoku

  • Nazifa Tasnim

  • Ambreen Yaseen

  • Oluwafemi Ogundiran

  • Sahana Subbiah

  • Mamuna Akram

  • Carmen Gan

  • Jafaru Abu

  • Santhanam Sundar

  • Srinivasan Madhusudan

  • Ketan Gajjar

  • September 3, 2026

Share

Original Source(s)

Correction: Time to adjuvant chemotherapy after cytoreductive surgery and survival outcomes in epithelial ovarian cancer: a retrospective cohort study

  • by Kshitij Jamdade, Marios Katsanevakis, Tobechi Njoku, Nazifa Tasnim, Ambreen Yaseen, Oluwafemi Ogundiran, Sahana Subbiah, Mamuna Akram, Carmen Gan, Jafaru Abu, Santhanam Sundar, Srinivasan Madhusudan, Ketan Gajjar

  • September 3, 2026

Related Content

Diet and Life After Prostate Cancer—the Journey From Evidence to Guidance Continues

Fellowship-Trained Neuro-Oncologist Nishika Karbhari, M.D., Joins Baptist Health Herbert Wertheim Cancer Institute

Fellowship-trained neuro-oncologist Nishika Karbhari, M.D., has joined Baptist Health Herbert Wertheim Cancer Institute.

  • by

  • September 3, 2026

  • 2 min
Toward Precision Cardio-Oncology in Breast Radiotherapy